Adverum Biotechnologies I... (ADVM)
4.16
-0.55 (-11.68%)
At close: Mar 03, 2025, 3:59 PM
4.16
0.00%
After-hours: Mar 03, 2025, 04:00 PM EST
Adverum Biotechnologies Ratios Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| PE Ratio | -0.65 | -0.37 | -1.19 | -7.85 | -11.45 | -26.62 | -27.22 | -9.24 | -51.12 | -483.67 | -1.1K | -3.21K |
| PEG Ratio | 0.03 | -0.08 | -0.16 | -0.21 | -0.02 | 3.12 | 0.46 | -0.13 | -0.77 | -1.39 | -5.9 | n/a |
| PS Ratio | 21.09 | n/a | 23.01 | n/a | 2.95K | 1.2K | 826.47 | 722.43 | 1.05K | 21.48K | 12.11K | 193.83K |
| PB Ratio | 0.91 | 0.32 | 0.55 | 2.12 | 4.22 | 9.61 | 8.30 | 4.88 | 9.60 | 82.20 | -26.67K | -5.83K |
| P/FCF Ratio | -0.83 | -0.48 | -1.4 | -10.13 | -10.79 | -35.3 | -32.91 | -25.78 | -63.28 | -1.86K | -2.57K | -4.58K |
| P/OCF Ratio | -0.84 | -0.53 | -1.6 | -11.64 | -15.02 | -35.83 | -33.64 | -27.4 | -68.64 | -2.18K | -2.67K | -4.59K |
| OCF/S Ratio | -25.25 | n/a | -14.38 | n/a | -196.68 | -33.48 | -24.57 | -26.37 | -15.24 | -9.87 | -4.53 | -42.23 |
| Debt / Equity Ratio | 0.90 | 0.59 | 0.33 | 0.07 | 0.18 | 0.00 | 0.00 | n/a | n/a | n/a | n/a | -0.49 |
| Quick Ratio | 4.13 | 5.91 | 14.88 | 20.82 | 9.06 | 19.48 | 18.15 | 22.76 | 39.70 | 29.30 | 0.71 | 0.46 |
| Current Ratio | 4.13 | 5.91 | 14.88 | 20.82 | 9.06 | 19.48 | 18.15 | 22.76 | 39.70 | 29.30 | 0.71 | 0.46 |
| Asset Turnover | 0.02 | n/a | 0.02 | n/a | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.44 | 0.08 |
| Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.36K | -47.32 | -227 |
| Return on Equity (ROE) | -1.4 | -0.85 | -0.46 | -0.27 | -0.37 | -0.36 | -0.31 | -0.53 | -0.19 | -0.17 | 24.20 | 1.82 |
| Return on Assets (ROA) | -0.68 | -0.5 | -0.33 | -0.24 | -0.29 | -0.34 | -0.28 | -0.48 | -0.18 | -0.16 | -4.86 | -4.69 |
| Return on Capital (ROIC) | -0.84 | -0.57 | -0.35 | -0.26 | -0.34 | -0.39 | -0.31 | -0.51 | -0.19 | -0.16 | 44.86 | 4.01 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | -56.78% | n/a | 38.07% | n/a | 100.00% | 100.00% | -13.36% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Net Profit Margin | -3.25K% | n/a | -1.94K% | n/a | -25.79K% | -4.51K% | -3.04K% | -7.82K% | -2.05K% | -4.44K% | -1.1K% | -6.04K% |
| Pretax Profit Margin | -3.28K% | n/a | -1.94K% | n/a | -25.79K% | -4.58K% | -3.04K% | -7.87K% | -2.05K% | -4.44K% | -1.1K% | -6.04K% |
| Operating Profit Margin | -3.44K% | n/a | -1.95K% | n/a | -27.42K% | -4.84K% | -3.18K% | -7.92K% | -2.06K% | -4.27K% | -719.58% | -6.05K% |
| FCF Margin | -2.55K% | n/a | -1.64K% | n/a | -27.37K% | -3.4K% | -2.51K% | -2.8K% | -1.65K% | -1.15K% | -472.08% | -4.23K% |
| EBITDA Margin | -3.29K% | n/a | -1.88K% | n/a | -25.17K% | -4.47K% | -2.92K% | -3.64K% | -2.02K% | -4.41K% | -734.17% | -6.07K% |